<<< BACK
|
NEWS
GlaxoSmithKline Oncology Selects Sam Brown
Inc.
as Public Relations Agency
Network-based agency provides specialized expertise,
senior account service and cost effective programs
to the health and science industries
Newtown Square, PA – October 10, 2001 - Sam
Brown Inc. Corporate Communications announced today that it has been
selected as the public relations agency of record to represent
GlaxoSmithKline’s Oncology franchise. Sam Brown Inc. is a corporate
communications agency that utilizes a network of senior consultants to
provide highly strategic and cost efficient communications solutions to
the health and science markets, with an emphasis on the pharmaceutical and
biotechnology industries.
Sam Brown Inc. will provide public relations services to support
GlaxoSmithKline’s Oncology franchise and brands, including Zofran® (ondansetron
HCl), Hycamtin® (topotecan hydrochloride), Navelbine® (vinorelbine
tartrate) Injection, Argatroban Injection, Alkeran® (melphalan) and Bexxar™
(tositumomab, iodine 131 tositumomab), a novel radioimmunotherapy agent in
late-stage development.
“It is particularly gratifying to win this account because it shows that
large clients also appreciate the value and efficiency of our network
model and it demonstrates that our approach is competitive with
traditional agencies,” said Laura M. Liotta, president of Sam Brown Inc.
“I believe we are building the agency of the future, offering
highly-skilled account and creative teams assembled from a large pool of
talent to meet specific client needs.”
Sam Brown Inc. is a full-service agency built on the philosophy that
experienced, senior health care communications professionals should
service client accounts. Through its unique structure, Sam Brown accesses
hundreds of professionals in its network tapping into specific strategic
and tactical expertise including public relations, investor relations,
media relations, scientific and consumer writing, research, creative and
Web design. Dedicated account teams are created based upon specific client
objectives and the strategic and tactical requirements of the program.
GlaxoSmithKline Oncology is the largest account in the Sam Brown Inc.’s
client roster, which also includes DuPont Pharmaceuticals, Yamanouchi
America Inc., Rohm and Haas Company, Ovarian Cancer National Alliance,
Drumbeat Digital and Dot Com Advisors.
“The Sam Brown model has advantages for our teams as well, because it
provides challenging assignments through a flexible work environment.
Because we emphasize talent and expertise, rather than location, our team
members can work from independent locations throughout the United States,”
continued Liotta. “We can also pursue clients and projects that are
particularly rewarding. The GlaxoSmithKline oncology assignment, for
example, offers us the opportunity to work on products that make a
substantial contribution to the quality of life of people living with
cancer and other life-threatening conditions.”
About Sam Brown Inc.
Founded in August 1999, Sam Brown Inc. Corporate Communications is a
full-service, health care agency that utilizes a network of experience
senior professionals to provide specialized expertise, quality strategic
programs and personalized service to the pharmaceutical and biotechnology
industries. For more information on Sam Brown Inc. services, or to join
the consultant network, visit
www.sambrown.com.
# # #
Copyright © 1994-2001
meister.NET. All rights reserved.
Legal Notices & Disclaimers
|
